Background: Catechol-O-methyltransferase (COMT) is a key enzyme responsible for the degradation of dopamine and norepinephrine. COMT activity influences cognitive and emotional states in humans and aggression and drug responses in mice. This study identifies the key sequence variant that leads to differences in Comt mRNA and protein levels among mice, and that modulates synaptic function and pharmacological and behavioral traits.
Introduction
Degradation of the catecholamine neurotransmitters dopamine, epinephrine, and norepinephrine is catalyzed by catechol-Omethyltransferase (COMT) and the monoamine oxidase enzymes. The mechanism of transmitter inactivation is distinct for each enzyme-methylation for COMT and deamination for monamine oxidase-and the impact each exerts on neurotransmitter tone varies by brain region. COMT is a key enzyme regulating dopamine tone in frontal neocortex in which expression is high relative to the monoamine oxidases and dopamine transporters, but COMT contributes less to dopamine tone in the striatum and nucleus accumbens [1, 2, 3, 4] . Dopamine levels play a critical role in the modulation of cognitive and emotional states, and changes in dopamine signaling are hallmarks of many psychiatric and addiction disorders. In humans, non-human primates, and rodents dopamine levels and cognitive performance have been described by an inverted U-shaped relation in which too much or too little extracellular dopamine has detrimental effects [5, 6, 7] .
Multiple SNPs have been identified that lead to changes in mRNA, protein, and/or activity levels but a single allele (Val108/ 158Met) accounts for most of the variation in the level of COMT activity in humans. Individuals homozygous for the Met allele have a 3-to 4-fold reduction in COMT activity and increased prefrontal cortex dopamine levels [8] . Although mice lack this particular polymorphism, several recent studies have shown that variation in Comt mRNA level [9] and activity [10] between C57BL/6J (B6) and DBA/2J (D2) mouse strains is associated with differences in aggression level and morphine sensitivity, respectively.
The B6 and D2 strains differ greatly on a wide variety of traits and their genomes are highly polymorphic with approximately 5 million identified sequence variants (www.sanger.ac.uk and www. genenetwork.org). A genetic reference population of B6 X D2 (BXD) recombinant inbred lines made by crossing these parental strains has been used extensively to explore differences in gene expression, neuropharmacology, and behavior, often using quantitative trait locus (QTL) mapping methods [11, 12] . The expression of Comt in this family of strains varies over 2-fold in several CNS regions and is strongly modulated by a polymorphism located within Comt itself [13] . However, there are no known SNPs between B6 and D2 in Comt, and the gene is situated in a , 8 Mb region that is identical by descent among most inbred strains. The genetic mechanism of the observed variation in Comt expression has been an unresolved question. In this paper we report the cloning of the cis sequence variant that controls Comt mRNA expression in many inbred strains and that produces widespread effects in the BXD family. The cause of this Comt cis-regulation is the insertion of a strong and premature polyadenylation signal in the proximal 39 UTR in B6 and several other strains. As a consequence these strains produce short 39UTRs compared to strains without the insertion. This is the first known variant in mice that causes variation in Comt expression. This mutation has effects on COMT activity and is clearly linked to downstream variation in expression of many other genes, dopamine tone, and behavior. We find both expected and novel biological roles for Comt that are relevant for the diagnosis and treatment of psychiatric and cognitive diseases in humans.
Results

Variation in
Comt mRNA expression and cis-regulation in CNS and peripheral tissues
We measured expression of Comt across multiple tissues in over 100 strains of mice and several large F2 intercrosses using four microrray platforms. Between strains and across tissue we consistently detect large differences in expression for probe sets that target both coding exons and the distal 39 UTR (Fig. 1A , Figure S1 , and Figure S2 ). We mapped this variation in Comt expression in several crosses, including the large BXD family. In this family, Comt expression maps to the location of the Comt gene itself (Fig. 1C and Fig. 1D ). Such differences that map back to the physical location of the gene are referred to as cis-regulated QTLs. For example in kidney, variation in the distal 39 UTR of the gene (probe set 1418701_at) maps to chromosome (Chr) 16 with an extremely high likelihood of the odds (LOD) score of 30 and a 2-LOD support interval from 17.5 to 19.8 Mb (Fig. 1D ). This demonstrates that sequence variants in or around the Comt gene control its expression. In this case, each copy of the D2 (D) allele increases Comt mRNA signal by a factor of two (Fig. 1B and www. genenetwork.org).
The expression of mRNA containing the distal 39 UTR (probe set 1418701_at) is strongly cis-modulated in all tissues and is associated with high expression from the D allele. In contrast, expression of more proximal coding exons (probe set 1449183_at) is not as strongly cis-regulated, is more variable across brain regions and organs, and is usually associated with higher expression from the B6 (B) allele (Fig. 1B) . Mean expression of the coding exons is higher and less variable among BXD strains than expression of the distal 39 UTR in all tissues (Fig. 2) . For example, there is over 44-fold variation in distal 39 UTR expression between the B and D alleles in the kidney compared to a 4-fold difference in coding exons from the same tissue. The pattern of high expression from the B allele for more proximal probe sets and high expression from the D allele for distal 39 UTR probe sets was replicated in the hippocampus and striatum using different microarray platforms ( Figure S3 ).
Profound differences in Comt expression were detected among highly diverse inbred strains of mice ( Figure S1 , Figure S2 ). Like B6, a small number of other common inbred strains, including 129S1/SvImJ, BALB/cByJ, A/J (A), C57BL/6ByJ, and AKR/J (AK), have low expression using the distal 39 UTR probe set. In contrast, and like D2, a larger number of strains, including C3H/ HeJ (H), CBA/CaJ, FVB/NJ, KK/HlJ, NZO/HlLtJ, NZW/LacJ, SJL/J, and all wild subspecies, have high expression. All crosses derived from strains that differed in Comt expression show strong cis-modulation. For example, progeny of crosses between B6 and H, B6 and CAST/EiJ, and AK and D2 demonstrate cismodulation whereas progeny of crosses between B6 and A, and C57BL/6ByJ and BALB/cByJ do not (Table S1) .
Collectively, these diverse mapping data sets demonstrate that expression of Comt is strongly cis-regulated and is caused by sequence variation in or around Comt itself. Surprisingly, B6, D2, and the great majority of strains are identical by descent for a large interval surrounding Comt. There are no known SNPs in Comt between B6 and D2 ( Fig. 3) and only 212 total SNPs between 15 and 23 Mb. The persistence of strong cis-modulation in the absence of SNPs provided a unique opportunity to identify the cryptic, but causal sequence variant in Comt.
Sequencing of the Comt locus
Next-generation whole genome sequencing data has recently been completed for the D2 strain using Applied Biosystems SOLiD and Illumina GA2 sequencing platforms (whole genome shotgun coverage of ,52x). A complete compendium of new D2 SNPs and other sequence variants in and around Comt is available at GeneNetwork (www.genenetwork.org) and from the Wellcome Trust Sanger Institute (http://www.sanger.ac.uk/resources/ mouse/genomes/). We identified large numbers of structural variants (copy number variants, translocations, inversions, and insertions and deletions) between B6 and D2, but none in the Comt interval. The sole exception was a 230 bp deletion in D2 ( Figure  S4 ). This insertion/deletion (indel) was located in the proximal 39 UTR (Chr 16 from 18,407,621-18,407,392 Mb). We sequenced the region around the indel in 8 strains with high or low expression (Fig. 4 ) and B6 and D2 reciprocal F1 hybrids. The presence or absence of the indel corresponded to the expression level detected by the distal 39 UTR probe set (1418701_at). Strains with the insertion, B6, BXD31, LG/J, and A/J (not shown), have low expression whereas strains without the insertion, D2, BXD76, PWK/PhJ, and KK/HIJ (not shown), have high expression.
To rule out the possibility that other sequence variants regulate Comt we queried genomic sequence data from seventeen inbred strains available from the Sanger Institute. We found no SNPs, indels, or haplotypes that segregate with the pattern of expression for a 62 Mb interval surrounding Comt. The only exception is an isolated indel that segregates perfectly among all strains with high or low distal 39 UTR expression. This indel is the only viable candidate for the massive cis-QTL in Comt. For this reason we closely examined this variant to understand the mechanisms that generate the strong cis eQTL.
Characterization of the 39 UTR indel in the comt locus
The 230 bp indel is a repetitive B2 family short interspersed element (SINE). B2 SINEs are a common type of retrotransposon representing ,2.4% of the mouse genome [14] . The B2 sequence contains several typical features, including a split RNA polymerase III promoter and termination signal. Of greater significance, this element also contains an array of overlapping polyadenylation signals flanked by an adenosine (A) rich segment in the 39 region [15, 16, 17] (Fig. 5A ). The insertion of this element and several premature polyadenylation sites in a subset of strains, including B6, should generate mRNA containing a shorter 39 UTR. In contrast, D2 and other strains that do not contain the SINE, should use the more distal and highly conserved polyadenylation site, and therefore produce a longer 39 UTR. We used 39 RACE and RNA sequencing (RNAseq) to test the effect of the introduced polyadenylation signal on 39 UTR length. As expected, the B6 strain produced a much shorter 39 UTR compared to D2 (Fig. 5B ) and there was a marked reduction in mRNA containing the distal 39 UTR in B6 ( Figure S5 ). The insertion of the B2 SINE produces variation in 39 UTR length that segregates among BXD strains and is the sole cause of cis-regulation of Comt expression. In the BXD panel, probe set measurements based on the distal 39 UTR detect the presence or absence of the long 39 UTR isoform and show consistent allelic regulation of expression ( Figure S1 , Figure S2 ). Probe sets that target coding exons do not discriminate between isoforms and more accurately reflect overall strain and tissue differences in total mRNA level. The genetic control of these probe sets was tissue specific. For example, highest expression of coding exons in the cerebellum, hippocampus, and striatum was associated with the B allele, whereas in prefrontal cortex and kidney, higher expression was generally associated with the D allele ( Fig. 1B and Fig. 2 ). This demonstrates that transacting factors and tissue specific transQTLs are also important modulators of Comt expression.
Independent of variation in total Comt levels, strains with the B2 SINE insertion primarily produce Comt with a short 39 UTR and strains without the insertion produce Comt with a long 39 UTR. It is possible that these differences in 39 UTR length have a functional consequence on protein level. In rodent brain a single transcript codes for both soluble (S-) and membrane bound (MB-) COMT through a leaky scanning mechanism [18] . We compared the level of both protein isoforms between strains in hippocampus and prefrontal cortex and both are expressed more highly in B6 (Fig. 6 ). Regardless of relative mRNA abundance between strains, B6 mRNA containing the shorter 39 UTR is associated with higher levels of COMT protein expression.
Impact of Comt gene sequence variation on downstream biological functions
What sets of higher order phenotypes are downstream of the Comt polymorphism? To answer this question we extracted all classical phenotypes in the GeneNetwork BXD phenotype database that map within 2 Mb of Comt. The prior probability of mapping near Comt is unusually low because this region is small (0.16% of the genome) and, with the exception of the B2 SINE polymorphism, is identical by descent (Fig. 3) . Even in massive expression data sets no more than 1-2 transcripts are expected to map to this region by chance. Twelve classical phenotypes with high content validity map to the Comt locus (p,0.02, Table S2 ), including binding affinity of both dopamine receptors (DRD1 and DRD2) in caudate, nucleus accumbens, ventral tegmental area, and prefrontal cortex [19] . Linkage of DRD1 and DRD2 binding was sex-specific and only detected in males. Sensitivity to the dopamine receptor antagonist haloperidol [20] and chloradiazepoxide, an allosteric modulator of GABA-A receptors [21] , also map to Comt.
To explore intermediate networks between Comt and the classic phenotypes listed above, we extracted transcripts modulated by Comt in four brain regions (Fig. 7, Table S3 ). Transcripts and genes with trans QTLs mapping into the Comt locus were filtered by expression level, biological relevance, and by examining expression in the Allen Institute for Brain Science (AIBS) brain atlas (www.brain-map.org). Downstream targets of Comt participate in cytoskeletal regulation (Cmip, Etnk1, and Ptprd), intracellular signaling (Cdc42, Araf, Hipk2, Cmip, Etnk1, Ptprd, and Rasgrp1), transport (Stau1, Adam10, Dnajc10, Mcoln1, Golga3, Arl7, Spo, Pitpnb, Ddx47, Capns1, and Kif5a), receptor/channel trafficking (Palm, Akap9, Sqstm1, Cntn2, Nsg1, and Dlgap1), synaptic maintenance and plasticity (Apba1, Tle3, Slit3, Slc12a6, Elavl4, and Syt1), transcriptional regulation (Nipbl, Myt1l, Ncor1, Jundm2, and Tef), and catecholamine metabolism (Maoa). Given the marked differences in expression of Comt covariates in different tissues and organs, we neither expected nor did we find significant overlap of its downstream targets. One exception was receptor protein tyrosine phosphatase delta (Ptprd). A key signaling molecule in the CNS involved in neurite growth [22] , deletion of Ptprd leads to learning and feeding impairments, in addition to alterations in hippocampal long-term potentiation [23] . There was significant overlap in gene function across data sets. Well supported categories included receptor trafficking, and synaptic maintenance/plasticity. Each region also included key genes associated with addiction (Maoa, Ptprd, and Slit3), psychiatric illnesses (Maoa, Myt1l, Slc12a6, and Slit3), and neurodegenerative diseases (Apba1 and Slc12a6).
Discussion
In this study we have identified the sequence variant underlying a strong cis-acting expression quantitative trait locus (eQTL) for the Comt gene. Comt is located in a large interval that is otherwise devoid of sequence variants between the BXD strains. In combination with strong mapping data, this provides definitive genetic and sequence support that the insertion of the B2 SINE into the proximal 39 UTR is the ultimate cause of the Comt eQTL. Based on expression data and corroborative sequence data, wild derived strains (MOLF/EiJ, CAST/EiJ, PWK/PhJ, and PWD/ PhJ) and Swiss mice (FVB/NJ and SJL/J) lack the insertion. Some strains derived from W. E. Castle and C. C. Little's stocks contain the insertion (C57BL/6J, A/J, 129S1/SvlmJ, and BALB/cByJ) whereas others do not (DBA/2J, 129P3/J, CBA/J, and C58/J). In the absence of the B2 SINE, inbred strains produce mRNA with a long 39 UTR. The insertion introduces a premature polyadenylation site and the production of a short isoform. The propagation of the B2 SINE in several strains derived by Castle and Little, as well as its absence in wild derived strains, is evidence that the long 39 UTR is ancestral. The short isoform is likely the result of a transposition fixed by inbreeding in the early 1900s. This naturally occurring mutation is likely to be the major source of variation in Comt expression among inbred strains.
The B2 SINE is associated with higher expression of Comt coding exons in B6 relative to D2 in the cerebellum, hippocampus, and striatum but not in the prefrontal cortex, ventral tegmental area, and nucleus accumbens. The B2 SINE insertion accounts for over 90% of the variance in mRNA length and expression across tissues but it is not the only mechanism governing expression. Approximately 50% of the variance of the common coding form is due to segregating trans-effects, non-segregating masking epistatic interactions, and residual error. Intriguingly, our protein analysis reveals that mRNA containing the short 39 UTR is translated at a higher level than mRNA containing the longer 39 UTR, regardless of relative isoform abundance in different tissues. This effect may be mediated by differences in secondary structure between isoforms, preferential binding to each isoform by factors regulating transport or translation, or by isoform differences in polyadenylation. The net result however is that the B2 SINE, by causing a change in the length of the 39 UTR, contributes significantly to genetic variation in COMT protein abundance. An increase in total COMT could be associated with higher enzymatic activity and previous research has demonstrated significantly higher COMT activity in the nucleus accumbens and prefrontal cortex of the B6 strain compared to D2 [10] . These results demonstrate a link between genomic sequence variation, transcript abundance, protein level, and enzymatic activity.
Variation in Comt message and protein levels caused by the B2 SINE influences multiple neurotransmitter systems, and has known and novel downstream effects on neuronal signaling and behavior (Fig. 7) . Key genes regulated by Comt are involved in catecholamine metabolism (Maoa), nervous system maintenance (Slc12a6), the excitatory postsynaptic density (Dlgap2), and receptor trafficking of AMPA (Palm, Sqstm1, and Nsg1) and NMDA (Akap9 and Apba1) receptors. The Comt downstream network also modulates synaptic transport (Stau1, Elavl4, Kif5a, and Syt1) and intracellular signaling (Hipk2, Araf, Cmip, and Etnk1). As expected, dopaminergic systems are clearly downstream of Comt, including Maoa in the striatum, DRD1 and DRD2 binding density in multiple brain regions, and the response to the dopamine receptor antagonist haloperidol. Finally, Comt modulates components of the glutamatergic and GABAergic systems and is linked to the expression of genes involved in excitatory synapse maintenance and locomotor responses to chlordiazepoxide, an allosteric modulator of GABA-A receptors.
The Comt variant exposes interconnectivity among neurotransmitter systems. From one perspective this may be surprising given the role of this enzyme in catecholamine catabolism, but even small changes at the end of a biochemical cascade feed back on transmitter synthesis and receptor trafficking to maintain homeostasis. Polymorphisms in COMT are often associated with CNS diseases such as schizophrenia, anorexia nervosa, bipolar disorder, anxiety, and substance use disorders [24] . These complex diseases have comparatively high genetic complexity, population heterogeneity, overlapping diagnostic criteria, modest additive effects of single polymorphisms, and a high likelihood that epistatic interactions influence disease risk [25, 26, 27, 28, 29] . The more widespread use of joint studies of mouse and human populations will provide an effective translational bridge. Genes and pathways that we have identified as sensitive to Comt variation in mice are attractive candidates in humans. Similarly, genes and pathways identified in human families and genome-wide association studies are attractive candidates to study using mouse reference populations.
There is significant divergence in COMT sequence and activity between mice and humans. A more efficient first initiation site in human COMT mRNA leads to the production of more membrane bound MB-COMT than soluble S-COMT in human brain [30] which, despite having a lower enzyme capacity, has a higher affinity for dopamine and other neurotransmitters [31, 32, 33] . In contrast, mice express both protein isoforms abundantly in brain. In humans multiple SNPs have been identified that lead to changes in mRNA, protein, and enzyme activity. In contrast, common strains of mice have little variation in Comt sequence, the B2 SINE, excepted. Additionally, mouse COMT, which contains Leu instead of Val at the equivalent position as the human Val108/158Met polymorphism, has higher activity than the Val allele [8] . In fact, amino acid substitution from Leu in mice to Val in monkeys and Met in humans substantially reduces COMT activity. This results in increased brain dopamine signaling in humans with important cognitive consequences. For example, Met polymorphisms, which decrease COMT activity, enhance working memory and attention [5, 34, 35, 36, 37, 38, 39] . However, the Met allele is associated with less pain and stress resiliency compared to the Val allele [40] . Despite the differences in the genetic regulation of Comt between mouse and human, manipulations point to very similar roles in cognition and behavior. Consistent with human studies, disruption of Comt in male mice elevates dopamine levels in the prefrontal cortex [2] and enhances working memory [30] . Conversely, overexpression of human COMT containing the Val polymorphism in mice leads to the disruption of working memory and attention and a reduction in sensitivity to pain and stress [30] .
Mammalian genomes contain a large proportion of transposable elements (TEs), including the Alu family of SINEs in humans, and B1 and B2 SINEs in rodents. TE insertions, such as the B2 SINE in Comt, are important drivers of gene evolution [16, 41] . Approximately 7% of genes in mice contain non-conserved polyadenylation sites derived from TEs [41] . These polyadenlyation sites can be co-opted to create novel mRNA structures that effect message processing, distribution, and translation. As in the case of Comt, insertion of a B2 SINE in the 39 UTR of major histocompatibility complex genes results in preferential usage of a premature polyadenylation signal [15] . Given the abundance of B1 and B2 SINES-564,000 and 348,000 copies, respectively [14] -it is highly likely that insertions of TEs modulate the expression of several other genes. These types of mutations, combined with intense selection, may have contributed to the rapid behavioral evolution of both wild populations and laboratory strains [42] . Both isoforms have higher expression in B6 compared to D2 in the prefrontal cortex (PFC) and hippocampus (HIP). Based on the amount of actin detected in the hippocampus it appears that there may be a slightly higher amount of protein in the D2 samples, however, the expression of MB-COMT and S-COMT is still higher in B6 compared to D2. doi:10.1371/journal.pone.0012181.g006
Methods
Ethics statement
All animal work was conducted according to an approved animal use protocol (UTHSC680) and in accordance with procedures approved by the Institutional Animal Care and Use Committee.
Expression and QTL analysis of Comt using GeneNetwork
Multiple expression datasets from many brain and peripheral tissues of inbred and RI strains were used in this analysis (see Text S1 for additional methods). Additional detailed descriptions of strain, sex, tissue preparation and microarray method for each individual database is available at www.genenetwork.org. Four microarray platforms were used in this analysis including; Agilent, Illumina, Affymetrix Exon 1.0 ST, and M430 arrays. Tools for QTL mapping and visualization are available at www.genenetwork.org [43, 44] .
Comt 39 UTR genomic DNA isolation and sequencing
Mice were purchased from Jackson Laboratory or bred inhouse. Mice were housed at the University of Tennessee Health Science Center in a pathogen-free colony in accordance with procedures approved by the Institutional Animal Care and Use Committee. Naive B6, D2, BXD31, BXD76, B6D2F1, D2B6F1, A/J, LG/J, PWK/PhJ, and KK/HlJ mice were killed at about 60 days of age by cervical dislocation.The liver was immediately collected and stored in RNALater (Ambion) at 4uC overnight. Genomic DNA was isolated using DNeasy Kits (QIAGEN) We used Primer 3 software to design custom forward (59-GCG CCA TCA TAC CTG AAA AG-39) and reverse (59-GGA AAA CAC CTG TGC ATCA A-39) primers specifically targeting Comt 39 UTR genomic DNA for amplification by PCR. PCR product size was predicted to be 608 bp based on available genomic data for the B6 reference strain. Coverage area within the Comt locus was from 18,407,151 to 18,407,758 Mb. DNA amplification was performed using the HotStar HiFidelity Polymerase kit (Qiagen) and 10 ng of genomic DNA for each strain followed by sequencing of the PCR products with each custom primer using an A3130XL Genetic Analyzer (Applied Biosystems). The resulting sequences were aligned against reference sequences from the NCBI GenBank database using nucleotide blast. The sequences were also aligned between strains using BLAST (bl2seq). The genomic DNA sequence of the Comt 39 UTR for the D2 strain is available at GenBank (GU324996).
Expression analysis using RNA -seq
Total RNA was isolated from the whole brains of 27BXD RI strains using RNA STAT-60 (Tel-Test Inc). Samples were DNase treated using a DNA-free kit (Ambion) to eliminate genomic DNA. The quality and purity of total RNA from each sample was assessed using an Agilent Bioanalyzer 2100 system. For RNA-seq, ribosomal RNA (rRNA) was removed from each total RNA sample using the RiboMinus Eukaryote Kit (Invitrogen). Each RNA sample was then converted to cDNA and amplified. Emulsion PCR was performed for each sample and each fragment library was subsequently sequenced on the Applied Biosystems SOLiD platform. This procedure preserves the strandedness (plus or minus) of the RNA read.
RNA-seq data processing and visualization
Short sequence reads were analyzed using Applied Biosystems whole transcriptome software tools (www.solidsoftwaretools.com/). Reads were mapped to the B6 reference genome (mm9, US National Center for Biotechnology Information (NCBI) build 37) with a minimum alignment score of 24.
Isolation and sequencing of Comt 39 UTR mRNA RNA STAT-60 (Tel-Test Inc) was used for RNA extraction from B6 and D2 hippocampus followed by ethanol precipitation. RNA quality was determined using a NanoDrop spectrophotometer (Thermo Scientific) and Agilent Bioanalyzer 2100 (Agilent). Target cDNA was generated using the FirstChoice RLM-RACE kit (Ambion) with minor modifications to the standard protocol (Text S1). The amplified products for each strain were purified with a PCR purification kit (Qiagen) and sequenced using both Comt 39 UTR forward primer and the 39 RACE inner primer separately. The mRNA sequence data for the B6 and D2 strain is available at GenBank (GU324998 contains B6 39 UTR mRNA sequence and GU324997 contains D2 39 UTR mRNA sequence). The full length of the 39 UTR is 553 and 789 nt for the B6 and D2 strain, respectively.
Protein extraction and immunoblotting
Fresh brain tissue from the hippocampus and prefrontal cortex was dissected from B6 and D2, snap-frozen in liquid nitrogen, and stored at 280uC followed by protein extraction (Text S1). Aliquots were created from each total protein extract and stored at 280uC until used for immunoblotting. Six total protein samples each from the hippocampus and prefrontal cortex of the B6 and D2 strain were used. Fifteen ug of protein was loaded on a NuPAGE 4212% Bis-Tris Gel (Invitrogen). Protein samples were separated by electrophoresis at 150 volts for 45 min before transferring to a PVDF membrane. Immunoblotting was performed using the WesternDot 625 goat anti-mouse Western blot kit (Invitrogen) according to the manufacturer's instructions (Text S1). Primary antibodies used in immunoblotting were mouse anti-COMT (clone 4/COMT, aa 26-141) and mouse anti-actin Ab5 (BD Transduction Laboratories). Images were acquired with an AlphaImager HP (Alpha Innotec).
Mapping traits to the Comt locus
We used a point-wise p-value of ,0.02 (LOD.1.73) to identify traits downstream of Comt. Phenotypes within the BXD Phenotype database were correlated with marker rs4165069 followed by marker regression to select traits with a significant marker association. Probe sets mapping to Comt were identified using the advanced search option in GeneNetwork across several Affymetrix M430 and Exon brain databases (Text S1). The advanced search option was used to detect probe sets with at least an LRS of 8 (LOD.1.73; p,0.02) and a mean expression level of 8 and 11 in the M430 and exon databases, respectively. False discovery rates for eQTL were conditioned by the likelihood that traits would map near Comt based on a target interval of 4 Mb and the relative density of sequence variants that produce eQTLs. Given these priors we expected less than 2 trans eQTL would map to the Comt interval by chance. Out of 24, 60, 18, and 30 probe sets mapping to the Comt locus in the hippocampus, striatum, prefrontal cortex and nucleus accumbens, respectively, we used our filtering criteria to select the 10 strongest traits controlled by variation in Comt from each region. Top probe sets were selected based on probe set specificity, strength of association to the Comt locus, biological function, and expression pattern for each relevant brain region in the AIBS (www.brain-map.org). Author Contributions
Supporting Information
